中文

Hong Kong Stocks · Free Data Page

TIGERMED 03347

TIGERMED: FY2025 revenue CN¥6.83B (+3.50% YoY); net income CN¥887.9M; 0 alerts, 2 watch items out of 17 risk checks; TTM dividend HK$0.14/sh.
Close PriceHK$40.28Day +6.39%Market CapHK$34.45BP/E—Negative earningsP/B1.51xDividend Yield0.36%TTMROE (FY2025)4.3%Avg. equity

Prices are closing data as of 2026-11-04, not real-time quotes. HK P/E and P/B multiples come from Eastmoney HK key statistics. Metric definitions: P/E, P/B, ROE.

Want the full AI research report for TIGERMED?

This free page compiles public filings, financial ratios and risk screening. Generate a full research report to add business moat & competition, valuation scenarios, catalysts and bull/bear cases right at this URL.

New users who sign up free and verify their email receive 2 free credits for research reports or professional valuation.

10-Year FinancialsFY2017–2025

Financial statements are reported in CNY, while share price and market cap are quoted in HKD.

Key Multi-Year Facts

  • Revenue moved from CN¥1.68B in FY2017 to CN¥6.83B in FY2025 (8-year CAGR +19.1%).
  • Profitable in every fiscal year across 2017–2025.
  • Operating cash flow was below half of net income in FY2021.

Latest 5 Fiscal Years

Fiscal Year20212022202320242025
Revenue (CNY B)5.217.097.386.606.83
YoY63.3%35.9%4.2%-10.6%3.5%
Net Income (CNY B)2.882.022.020.410.89
YoY64.4%-30.0%0.4%-80.0%119.2%
Operating Cash Flow (CNY B)1.161.131.151.101.12
ROE16.8%10.7%10.0%1.9%4.3%
Gross Margin43.1%39.3%38.6%34.0%27.4%
Net Margin55.2%28.5%27.4%6.1%13.0%
Debt-to-Assets13.2%17.4%17.6%16.1%14.5%
Show all 9 fiscal years
Fiscal Year201720182019202020212022202320242025
Revenue (CNY B)1.682.302.803.195.217.097.386.606.83
YoY—36.7%21.9%13.9%63.3%35.9%4.2%-10.6%3.5%
Net Income (CNY B)0.340.580.841.752.882.022.020.410.89
YoY—67.2%45.8%108.2%64.4%-30.0%0.4%-80.0%119.2%
Operating Cash Flow (CNY B)0.310.510.540.891.161.131.151.101.12
ROE13.5%21.4%23.8%17.2%16.8%10.7%10.0%1.9%4.3%
Gross Margin42.4%42.7%46.1%47.1%43.1%39.3%38.6%34.0%27.4%
Net Margin20.5%25.1%30.0%54.9%55.2%28.5%27.4%6.1%13.0%
Debt-to-Assets22.6%28.7%27.0%8.4%13.2%17.4%17.6%16.1%14.5%

Fiscal years follow the period-end calendar year (hover headers for period-end dates). ROE uses average beginning/ending equity. Source: HKEX / Eastmoney financial statements, compiled mechanically without AI. Official filings

Risk ChecklistAs of 2026-11-05

Rules-based screening using HK financial statements and HKEX announcement categories (no AI opinions).

0Alert 2Watch 15Pass

Items Flagged for Review

  • Watch

    GoodwillFinancial Quality

    CN¥3.46B, 17.6% of equity

    Q3 (2026-09-30) · What is this?

  • Watch

    Profit WarningMaterial Events

An "Alert" or "Watch" item flags a number that merits verification in primary filings, not a sell signal.

Dividends

Trailing 12-month dividend: HK$0.145 per share, or 0.36% yield at closing price; last full fiscal year: HK$0.145 (payout ratio -27.0%).

Figures are gross HKD per share before applicable withholding or Stock Connect dividend taxes.

More data: All research reports · Sector leaders · Market hours & holidays.

Compiled mechanically from public filings and market quotes (data as of 2026-11-05). For informational purposes only, not investment advice.